MOSCOW, February 5, 2013 /PRNewswire/ --
Collaboration provides ROSATOM with access to ScienceDirect and Scopus, fostering international expertise and the launch of new technologies and innovations in safe nuclear energy
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today its collaboration with Russia's State Atomic Energy Corporation (ROSATOM), providing ROSATOM's major affiliated research organizations with access to Elsevier's ScienceDirect and Scopus.
ROSATOM unites a number of Russia's key enterprises focusing on atomic power engineering, nuclear and radiation safety and fundamental and applied research in the creation of structural materials and technologies. The corporation actively participates in international energy research and develops innovative technologies in water treatment, new isotopes for medicine and in superconductivity. By providing more than ten of its key enterprises with access to ScienceDirect and Scopus, ROSATOM will help these institutes to significantly advance and accelerate their research and innovation in atomic energy.Svetlana Sheveleva, Deputy Director on Innovation Complex at ROSATOM, said, "As one of the world's leaders in atomic energy, we aim to be a world-class research organization. Our research leads to the discovery of new technologies in medicine, material science and other actual fundamental and applied areas. Without access to world-class scientific information, resources and tools, this would not be possible. Our collaboration with Elsevier helps us reach our objectives." Igor Osipov, PhD, Regional Director at Elsevier Russia and Belarus, added, "Rosatom is one of the global leaders in safe nuclear energy research and we have collaborated with their flagship R&D think tank - Russian Federal Nuclear Center (RFNC-VNIIEF) for many years. We are happy to take this collaboration to the next level by providing access to ScienceDirect and Scopus to the entire network of R&D organization within ROSATOM. Through our agreement with ROSATOM, Elsevier can contribute to the development of high quality research and innovation in the Russian and international energy sector." About ROSATOM
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts